Hot Features
Premium
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Zeitraum:
Zeichenmodus:
| Volumen | 347.911 |
|
|||||
| News | - | ||||||
| Tageshoch | 1,84 | Niedrig Hoch |
|||||
| Tagestief | 1,70 | ||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| NanoViricides Inc | NNVC | AMEX | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,12 | 6,98% | 1,84 | 01:58:51 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 1,75 | 1,70 | 1,84 | 1,85 | 1,72 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|---|---|
| 1.431 | 347.911 | US$ 1,76 | US$ 613.005 | - | 1,00 - 3,59 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 01:59:13 | 2 | US$ 1,8399 | USD |
Finanzwerte NNVC
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 21,38M | 11,81M | - | 0 | -8,59M | -0,73 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News NanoViricides
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 02.5.2024 | 16:07 | InvestorsHub NewsWire | NanoViricides Reports that the Phase I NV-387 Clinical Trial.. |
| 16.2.2024 | 22:53 | Edgar (US Regulatory) | Form 8-K - Current report |
| 14.2.2024 | 22:55 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 19.1.2024 | 22:44 | Edgar (US Regulatory) | Form 8-K - Current report |
| 04.12.2023 | 22:08 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 13.10.2023 | 22:30 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 28.9.2023 | 22:44 | Edgar (US Regulatory) | Form NT 10-K - Notification of inability to timely file Form.. |
| 01.9.2023 | 22:46 | Edgar (US Regulatory) | Form 8-K - Current report |
| 06.7.2023 | 17:16 | InvestorsHub NewsWire | Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is.. |
Forum NanoViricides
Keine Diskussionen Gefunden.Neuen Thread Erstellen
NNVC Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 2,04 | 2,07 | 1,65 | 1,84 | 389.263 | -0,20 | -9,80% |
| 1 Monat | 2,40 | 3,59 | 1,63 | 2,36 | 444.864 | -0,56 | -23,33% |
| 3 Monate | 1,34 | 3,59 | 1,0297 | 2,16 | 276.518 | 0,50 | 37,31% |
| 6 Monate | 1,01 | 3,59 | 1,0074 | 2,04 | 148.310 | 0,83 | 82,18% |
| 1 Jahr | 1,17 | 3,59 | 1,00 | 1,85 | 107.198 | 0,67 | 57,26% |
| 3 Jahre | 4,59 | 7,86 | 1,00 | 4,68 | 354.457 | -2,75 | -59,91% |
| 5 Jahre | 0,25 | 19,80 | 0,16045 | 7,08 | 692.238 | 1,59 | 636,00% |
